The trans Effect in Palladium Phosphine Sulfonate Complexes.

Palladium phosphine sulfonate complexes constitute an efficient family of catalysts for both homopolymerization of ethylene and copolymerization of ethylene with a number of polar monomers. Their catalytic mechanisms have been extensively studied but not fully understood at the electronic structure level. The energy decomposition analysis, complemented with the inspection of the natural orbitals for chemical valence, reveals that their catalytic activity can be rationalized in terms of the so-called trans effect. Furthermore, our analysis shows that the competition for the σ donation of the two ligands PMe3 and L, of the palladium phosphine sulfonate complexes, to the same orbital of Pd in the trans isomer and to different orbitals in the cis isomer is the origin of the trans effect. Although the dominance of the phosphine group prevents an efficient interaction of the ligand L with the Pd atom, the large stabilization gained by the phosphine group renders a very stable trans complex.

Ultrabroadband terahertz spectroscopy of a liquid crystal.

Liquid crystals (LCs) are becoming increasingly important for applications in the terahertz frequency range. A detailed understanding of the spectroscopic parameters of these materials over a broad frequency range is crucial in order to design customized LC mixtures for improved performance. We present the frequency dependent index of refraction and the absorption coefficients of the nematic liquid crystal 5CB over a frequency range from 0.3 THz to 15 THz using a dispersion-free THz time-domain spectrometer system based on two-color plasma generation and air biased coherent detection (ABCD). We show that the spectra are dominated by multiple strong spectral features mainly at frequencies above 4 THz, originating from intramolecular vibrational modes of the weakly LC molecules.

Effects of enzyme replacement therapy on growth in patients with mucopolysaccharidosis type II.

Mucopolysaccharidosis type II (MPS II; Hunter syndrome) is an X-linked, recessive, lysosomal storage disorder caused by deficiency of iduronate-2-sulfatase. It has multisystemic involvement, with manifestations in the brain, upper respiratory tract, heart, abdomen, joints and bones. Bone involvement leads to decreased growth velocity and short stature in nearly all patients. A therapeutic option for patients with MPS II is enzyme replacement therapy (ERT) with idursulfase (Elaprase®). We compared annual growth rates before and during ERT in 18 patients from Mainz, Germany, and Manchester, UK. Group 1 included nine patients who started ERT before 10 years of age; group 2 contained nine patients aged more than 10 years at the start of ERT. All patients had received weekly or biweekly ERT or placebo for 1 year, followed by ERT for more than 3 years. For patients in group 1, the mean (± SD) height increase was 14.6 ± 5.5 cm during 3 years of ERT. Only one patient in this group (who was below the 3rd percentile when starting ERT) deviated from the normal growth curve over this time. Patients in group 2 had a mean height increase of 8.1 ± 1.7 cm after 3 years of ERT compared with an increase of 1 cm in the year before ERT. ERT seems to have a positive influence on growth in patients with MPS II. Most benefit is seen in patients beginning ERT before the age of 10 years. This supports the recommendation that ERT should be started as early as possible in patients with MPS II.

Dinitrogen complexation and reduction at low-valent calcium.

Here we report that attempted preparation of low-valent CaI complexes in the form of LCa-CaL (where L is a bulky ß-diketiminate ligand) under dinitrogen (N2) atmosphere led to isolation of LCa(N2)CaL, which was characterized crystallographically. The N2 2- anion in this complex reacted in most cases as a very potent two-electron donor. Therefore, LCa(N2)CaL acts as a synthon for the low-valent CaI complex LCa-CaL, which was the target of our studies. The N2 2- anion could also be protonated to diazene (N2H2) that disproportionated to hydrazine and N2 The role of Ca d orbitals for N2 activation is discussed.

Asymmetric intramolecular aldol reactions of substituted 1,7-dicarbonylic compounds. A mechanistic study.

The diastereo- and enantioselectivity obtained experimentally by List on the proline-catalyzed intramolecular aldol reaction of substituted 1,7-dicarbonylic compounds was accurately predicted using density functional theory methods at the B3LYP/6-31++G** level. A polarizable continuum model was used to describe solvent effects. The theoretical data agree in good extension with List's experimental results, both in enantioselectivity and diastereoselectivity, and allow for the confirmation of our previous rationalization of the main factors contributing to the reaction selectivity. While the enantioselectivity results from an important electrostatic contact between the forming alkoxyde group and the proline moiety, the calculated diasteroselectivity results from several steric contacts that can be established between the different substituents and from their relative orientation in respect to the ring conformation. However, for dialdehydes that can originate two diastereomeric enamine intermediates, the proline attack and the immonium formation steps can also be of major importance in the rationalization of the final reaction selectivity, as is the case in two of the six studied systems. The obtained data allows for a full rationalization of the known experimental systems as well as for the extrapolation to new ones with variable substitution at the carbonylic chain.

Phloretin keto-enol tautomerism and inhibition of glucose transport in human erythrocytes (including effects of phloretin on anion transport).

Under various pH conditions phloretin demonstrates keto-enol tautomerism with a pK value of 7.26 +/- 0.06. As Wilbrandt has shown ((1950) Arch. Exp. Pathol. Pharmacol. 212, 9-29) phloretin added to erythrocytes inhibits glucose efflux, but not glucose influx. At pH 6.5 a Ki value of 0.36 and at pH 9 of 22.7 microM was measured; only the ketonic form of phloretin contributes to the inhibition of glucose efflux. This was also the case for inhibition of galactose efflux and anion exchange. The geometry optimization of a large number of conformations of the ketonic and enolic forms of phloretin demonstrates different shapes of the molecules. Only the ketonic form shows several overlapping structures with beta-D-glucopyranose. Considering surplus binding of phloretin under glucose efflux conditions as being equivalent to the number of glucose transporters, a number of about 200,000 molecules was determined. By two independent methods 210,000 and 171,000 molecules per cell were calculated. This result is in close agreement with the number of glucose transporter sites of the erythrocyte.

Effects of addition of a 2-methyl group to ethyl nipecotates (beta-meperidines) on receptor affinities and opiate agonist/antagonist activities.

A series of 2-methyl-3-carbethoxy-3-(m-hydroxyphenyl)piperidine opiates (13a-d) with N-substituent variations have been synthesized, and their receptor affinities and in vivo agonist and antagonist activities and energy-conformational profiles have been determined. These are racemates of the alpha-epimer at the C-2 position, with a methyl group cis to the 3-phenyl group. One of the main goals of this study was to compare the conformational and pharmacological behavior of these 2-methyl "beta-meperidine" analogues to their 2-desmethyl racemic counterparts (14a-c) previously reported in the literature. The 2-desmethyl and 2-methyl analogues were found to have very similar phenyl equatorial conformers as their lowest energy forms with the addition of a 2-methyl group diminishing conformational flexibility. The presence of the 2-methyl group appears to diminish affinity at the mu-receptor and also to somewhat diminish already weak antinociceptic agonist activity. Given the similarity in lowest energy conformation, this reduction is most likely caused by the unfavorable interaction of the methyl group itself with a local mu-receptor binding site. Superposition of the phenol OH and protonated amine nitrogen NH of either 2-methyl enantiomer of 13a in its lowest energy conformer with the same OH and NH groups of metazocine, used as a high affinity rigid analogue, leads to reasonable overlap. However, the N-substituents and the piperidine and phenyl rings do not overlap in this proposed pharmacophore, perhaps accounting for the rather poor affinities found for these 3-phenylpiperidines and the lack of N-substituent modulation of affinity and efficacy as in fused ring opioids.

Effect of structural modifications in the C7-C11 region of the retinoid skeleton on biological activity in a series of aromatic retinoids.

A series of conformationally restricted analogues of (E)-4-[2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)propenyl ] benzoic acid--(E)-4-[1-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-2 - propenyl]benzoic acid, (E)-4-[3-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-2-bu ten- 2-yl]benzoic acid, trans-4-[2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl) cyclopropyl]benzoic acid, 4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid, 6-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-2- naphthalenecarboxylic acid, 6-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)-2- naphthalenecarboxylic acid and 6-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-5-methyl-2- naphthalenecarboxylic acid--were synthesized and screened for retinoid biological activity. Comparison of the conformers of these analogues generated by molecular mechanics calculations with the biological activity profiles of these compounds indicates that geometric constraints required for high biological activity are imposed on the bridge joining the two aromatic ring systems by the retinoid receptor.

In search of catalytically active species in the surfactant-mediated biphasic alkene epoxidation with Mimoun-type complexes.

[figure: see text] A biphasic protocol for the catalytic olefin epoxidation with Mimoun-type complexes [MoO(O2)2(OPR3)] (1) was recently patented by BASF. Density-functional calculations have been carried out to identify potentially active species in addition to the parent complex 1. It has been found that the (mu 2,eta 1:eta 2-O2)-bridged dimer [MoO(O2)2(OPR3)]2 is significantly less reactive than the monomer. The calculations show that the parent complex is strongly activated by protons coordinating with the peroxo functionalities.

Keratan sulphate levels in mucopolysaccharidoses and mucolipidoses.

The mucopolysaccharidoses (MPS) is characterized by accumulation of glycosaminoglycans (GAGs), and mucolipidosis (ML) by accumulation of GAGs and sphingolipids. Each type of MPS accumulates specific GAGs. The lysosomal enzymes N-acetylgalactosamine-6-sulphate sulphatase and beta-galactosidase involve the stepwise degradation of keratan sulphate (KS). Deficiency of these enzymes results in elevation of KS levels in the body fluids and in tissues, leading to MPS IV disease. In this study, we evaluated blood and urine KS levels in types of MPS and ML other than MPS IV. Eighty-five plasma samples came from MPS I (n = 18), MPS II (n = 28), MPS III (n = 20), MPS VI (n = 3), MPS VII (n = 5) and ML (n = 11) patients while 127 urine samples came from MPS I (n = 34), MPS II (n = 34), MPS III (n = 32), MPS VI (n = 7), MPS VII (n = 9) and ML (n = 11) patients. KS levels were determined using the ELISA method. Plasma KS levels varied with age in both control and patient populations. In all age groups, the mean values of plasma KS in MPS and ML patients were significantly higher than those in the age-matched controls. Plasma KS values in four newborn patients were above the mean + 2SD of the age-matched controls (mean, 41 ng/ml). Overall, 85.9% of individual values in non-type IV MPS and ML patients were above the mean + 2SD of the age-matched controls. For urine KS levels, 24.4% of individual values in patients were above the mean + 2SD of the age-matched controls. In conclusion, KS in blood is elevated in each type of non-type IV MPS examined, in contrast to the conventional understanding. This finding suggests that measurement of KS level provides a new diagnostic biomarker in a wide variety of mucopolysaccharidoses and mucolipidoses in addition to MPS IV.

Heparan sulfate levels in mucopolysaccharidoses and mucolipidoses.

Glycosaminoglycans are accumulated in both mucopolysaccharidoses (MPS) and mucolipidoses (ML). MPS I, II, III and VII and ML II and ML III patients cannot properly degrade heparan sulphate (HS). In spite of the importance of HS storage in the metabolic pathway in these diseases, blood and urine HS levels have not been determined systematically using a simple and economical method. Using a new ELISA method using anti-HS antibodies, HS concentrations in blood and urine were determined in MPS and ML II and ML III patients. HS concentrations were determined in 156 plasma samples from MPS I (n = 23), MPS II (n = 26), MPS III (n = 24), MPS IV (n = 62), MPS VI (n = 5), MPS VII (n = 5), ML II (n = 8) and ML III (n = 3), and 205 urine samples from MPS I (n = 33), MPS II (n = 33), MPS III (n = 30), MPS IV (n = 82), MPS VI (n = 7), MPS VII (n = 9), ML II (n = 8) and ML III (n = 3). The ELISA method used monoclonal antibodies against HS. MPS I, II, III and VII and ML II and III patients had significant elevation in plasma HS, compared to the age-matched controls (p < 0.0001). Eighty-three out of 89 (93.3%) of individual values in the above MPS types and ML were above the mean +2SD of the controls. In urine samples, 75% of individual values in patients with those types were above the mean +2SD of the controls. In contrast to the previous understanding of the HS metabolic pathway, plasma HS levels in all five MPS VI and 15% of MPS IV patients were elevated above the mean +2SD of the controls. These findings suggest that HS concentration determined by ELISA, especially in plasma, could be a helpful marker for detection of the most severe MPS I, II, III, VI and VII and ML II, distinguishing them from normal populations.

Energy analysis of metal-ligand bonding in transition metal complexes with terminal group-13 diyl ligands (CO)(4)Fe-ER, Fe(EMe)(5) and Ni(EMe)(4) (E = B-Tl; R = Cp, N(SiH(3))(2), Ph, Me) reveals significant pi bonding in homoleptical molecules.

The metal-ligand bonds of the title compounds have been investigated with the help of an energy partitioning analysis at the DFT level. It was found that the attractive orbital interactions between Fe and ER in (CO)(4)Fe-ER arise mainly from Fe <-- ER sigma donation. Only the boron diyl complexes (CO)(4)Fe-BR have significant contributions by Fe --> ER pi back-donation, but the Fe <-- BR sigma-donation remains the dominant orbital interaction term. The relative contributions of Fe-ER sigma donation and pi back-donation are only slightly altered when R changes from a good pi donor to a poor pi donor. Electrostatic forces between the metal fragment and the diyl ligand are always attractive, and they are very strong. They arise from the attraction between the local negative charge concentration at the overall positively charged donor atom E of the Lewis base ER and the positive charge of the iron nucleus. Electrostatic interactions and covalent interactions in (CO)(4)Fe-ER complexes have a similar strength when E is Al--Tl and when R is a good pi donor substituent. The Fe-BR bonds of the boron carbonyldiyl complexes have a significantly higher ionic character than the heavier group-13 analogues. Weak pi donor substituents R enhance the ionic character of the (CO)(4)Fe-ER bond. The metal-ligand bonds in the homoleptic complexes Fe(EMe)(5) and Ni(EMe)(4) have a higher ionic character than in (CO)(4)Fe-ER. The contribution of the TM --> ER pi back-donation to the Delta E(orb) term becomes clearly higher and contributes significantly to the total orbital interactions in the homoleptic complexes where no other pi acceptor ligands are present. The ligand BMe is nearly as strong a pi acceptor in Fe(BMe)(5) as CO is in Fe(CO)(5).

Structure and bonding of transition metal-boryl compounds. Theoretical study of [(PH3)2(CO)ClOs-BR2] and [(PH3)2(CO)2ClOs-BR2] (BR2 = BH2, BF2, B(OH)2, B(OCH=CHO), Bcat).

Quantum chemical DFT calculations using the B3LYP functionals have been carried out for the electronically unsaturated 16 VE five-coordinate osmium boryl-complexes [(PH3)2(CO)ClOs-BR2] and the 18 VE six-coordinate complexes [(PH3)2(CO)2ClOs-BR2] with BR2 = BH2, BF2, B(OH)2, B(OHC=CHO), and Bcat (cat = catecholate O2C6H4). The bonding situation of the Os-BR2 bond was analyzed with the help of the NBO partitioning scheme. The Os-B bond dissociation energies of the 16 VE complexes are very high, and they do not change very much for the different boryl ligands. The 18 VE complexes have only slightly lower bond energies than the 16 VE species. The Os-B bond in both classes of compounds is provided by a covalent sigma-bond which is polarized toward osmium and by strong charge attraction. Os-->B pi-donation is not important for the Os-B binding interactions, except for the Os-BH2 complexes. The stability of the boryl complexes [Os]-BR2 comes mainly from B<--R pi-donation, which is clearly higher than the Os-->B pi-donation. The intraligand charge distribution of the BR2 group changes little when the Os-B bond is formed, except for BH2. The CO ligand in [(PH3)2(CO)2ClOs-BR2] which is trans to BR2 has a relatively weak bond to the osmium atom.

Theoretical studies of molybdenum peroxo complexes [MoOn(O2)3-n(OPH3)] as catalysts for olefin epoxidation.

The equilibrium geometries of the molybdenum oxo/peroxo compounds MoOn(O2)3-n and the related complexes [MoOn(O2)3-n(OPH3)] and [MoOn(O2)3-n(OPH3)(H2O)] (n = 0-3) have been calculated using gradient-corrected density-functional theory at the B3LYP level. The structures of the peroxo complexes with ethylene ligands [MoOn(O2)3-n(C2H4)] and [MoOn(O2)3-n(OPH3)(C2H4)] (n = 1, 2) where ethylene is directly bonded to the metal have also been optimized. Calculations of the metal-ligand bond-dissociation energies show that the OPH3 ligand in [MoOn(O2)3-n(OPH3)] is much more strongly bound than the ethylene ligand in [MoOn(O2)3-n(C2H4)]. This makes the substitution of phosphane oxide by olefins in the epoxidation reaction unlikely. An energy-minimum structure is found for [MoO(O2)2(OPH3)(C2H4)], for which the dissociation of C2H4 is exothermic with D0 = -5.2 kcal/mol. The reaction energies for the perhydrolysis of the oxo complexes with H2O2 and the epoxidation of ethylene by the peroxo complexes have also been calculated. The peculiar stability of the diperoxo complex [MoO(O2)2(OPH3)(H2O)] can be explained with the reaction energies for the perhydrolysis of [MoOn(O2)3-n(OPH3)(H2O)]. The first perhydrolysis step yielding the monoperoxo complex is less exothermic than the second perhydrolysis reaction, but the further reaction with H2O2 yielding the unknown triperoxo complex is clearly endothermic. CDA analysis of the metal-ethylene bond shows that the binding interactions are mainly caused by charge donation from the ligand to the metal.

Theoretical structure-activity studies of methyl-substituted 4-(m-OH phenyl) piperidines.

The theoretically determined molecular structures of N-protonated 1,3,4,6 methyl-substituted 4-(m-OH phenyl) piperidines are correlated to their experimentally derived analgesic activities. It is concluded that the orientation of the 3-methyl group plays a crucial role in determining agonism and antagonism.

[2+2] versus [3+2] addition of metal oxides across C=C double bonds: toward an understanding of the surprising chemo- and periselectivity of transition-metal-oxide additions to ketene.

The peri-, chemo-, stereo-, and regioselectivity of the addition of the transition-metal oxides OsO4 and LReO3 (L = O-, H3PN, Me, Cp) to ketene were systematically investigated using density-functional methods. While metal-oxide additions to ethylene have recently been reported to follow a [3+2] mechanism only, the calculations reveal a strong influence of the metal on the periselectivity of the ketene addition: OsO4 again prefers a [3+2] pathway across the C=C moiety whereas, for the rhenium oxides LReO3, the [2+2] barriers are lowest. Furthermore, a divergent chemoselectivity arising from the ligand L was found: ReO4- and (H3PN)ReO3 add across the C=O bond while MeReO3 and CpReO3 favor the addition across the C=C moiety. The calculated energy profile for the MeReO3 additions differs from the CpReO3 energy profile by up to 45 kcal/mol due to the stereoelectronic flexibility of the Cp ligand adopting eta5, eta3, and eta1 bonding modes. The selectivity of the cycloadditions was rationalized by the analysis of donor-acceptor interactions in the transition states. In contrast, metal-oxide additions to diphenylketene probably follow a different mechanism: We give theoretical evidence for a zwitterionic intermediate that is formed by nucleophilic attack at the carbonyl moiety and undergoes a subsequent cyclization yielding the thermodynamically favored product. This two-step pathway is in agreement with the results of recent experimental work.

Iron bispentazole Fe(eta5-N5)2, a theoretically predicted high-energy compound: structure, bonding analysis, metal-ligand bond strength and a comparison with the isoelectronic ferrocene.

Quantum-chemical calculations with gradient-corrected (B3LYP) density functional theory have been carried out for iron bispentazole and ferrocene. The calculations predict that Fe(eta5-N5)2 is a strongly bonded complex which has D5d symmetry. The theoretically predicted total bond energy that yields Fe in the 5D ground state and two pentazole ligands is Do = 109.0 kcal mol(-1), which is only 29 kcal mol(-1) less than the calculated bond energy of ferrocene (Do = 138.0 kcal mol(-1); experimental: 158 +/- 2 kcal mol(-1)). The compound Fe(eta5-N5)2 is 260.5 kcal mol(-1) higher in energy than the experimentally known isomer Fe(N2)5, but the bond energy of the latter (Do = 33.7 kcal mol(-1)) is much less. The energy decomposition analyses of Fe(eta5-N5)2 and ferrocene show that the two compounds have similar bonding situations. The metal-ligand bonds are roughly half ionic and half covalent. The covalent bonding comes mainly from (e1g) eta5-N5- --> Fe2+ pi-donation. The previously suggested MO correlation diagram for ferrocene is nicely recovered by the Kohn-Sham orbitals. The calculated vibrational frequencies and IR intensities are reported.

Reaction of Ni2Cp2(mu-CO)2 with the alkylgallium(I) and alkylindium(I) compounds E4[C(SiMe3)3]4 (E = Ga, In). Insertion of E-R groups into the Ni-Ni bond versus replacement of CO by the isolobal E-R ligands.

The monomeric fragment In-C(SiMe3)3 was inserted into the Ni-Ni bond of Ni2Cp2(mu-CO)2 upon treatment of the carbonyl complex with the tetraindium(I) compound In4[C(SiMe3)3]4, 1, in a molar ratio of 4 to 1. The product (3) contains an indium atom coordinated to one alkyl substituent and two Ni(Cp)CO groups in a planar coordination sphere. Reaction of the starting compounds in a molar ratio of 2 to 1 led to the replacement of both CO ligands by two InR groups. A compound (4) was formed that is isostructural to the carbonyl nickel complex and has a Ni2 couple bridged by two InR ligands and two terminally coordinated cyclopentadienyl groups. The insertion product was not observed with the gallium derivative Ga4[C(SiMe3)3]4 (2); instead, a nickel gallium complex (5) analogous to 4 containing two bridging GaR ligands was isolated as the only product regardless of the ratio of the starting compounds. On the basis of quantum chemical calculations, we conclude that there is no evidence for an In-In or Ga-Ga bond in complexes 4 or 5, respectively. This, however, supports a butterfly geometry, which is isostructural to the starting carbonyl complex Ni2Cp2(mu-CO)2.